Please login to the form below

Not currently logged in
Email:
Password:

ABPI names latest Code breaches

Bayer Healthcare, Chiesi and Eli Lilly and Company have been called out for breaches of the Association of the British Pharmaceutical Industry's Code of Practice, while Bayer Schering Pharma has been publicly reprimanded

Bayer Healthcare, Chiesi and Eli Lilly and Company have been named in advertisements for breaches of the Association of the British Pharmaceutical Industry's (ABPI) Code of Practice, while Bayer Schering Pharma has been publicly reprimanded.

Bayer Healthcare, Chiesi, Eli Lilly were found to have breached Clause 2 of the ABPI Code of Practice - administered by the Prescription Medicines Code of Practice Authority (PMCPA) - bringing discredit upon, and reducing confidence in, the pharmaceutical industry.

Meanwhile Bayer Schering Pharma has been reprimanded for failing to include prescribing information.

The breaches will be highlighted in advertisements in the medical, pharmaceutical and nursing press.

The PMCPA May Code of Practice Review (PDF) has further information on the breaches of the Code.

31st May 2011

Share

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

The importance of accelerating clinical trial diversity
Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
Digital Opinion Leaders: The Role of Influencers in Medical Communications
There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
Creating Hope Though Action – World Suicide Prevention Day
At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....